Learn More
Medchemexpress LLC Ath686 | 853299-52-2 | MFCD22665713 | 99.5% | 515.53 | C25H28F3N7O2 | 10 MG

Supplier: Medchemexpress LLC HY1500310MG
ATH686 is a potent, selective, ATP-competitive FLT3 kinase inhibitor used in research to study FLT3-mutant leukemia. It inhibits mutant FLT3 activity, induces apoptosis, and suppresses proliferation in FLT3-mutant cells.
- Potent, selective ATP-competitive FLT3 inhibition.
- Demonstrated induction of apoptosis and cell-cycle arrest in FLT3-mutant cells.
- High purity suitable for biochemical and cellular assays.
- Available as solid and as 10 mM solution in DMSO for convenience.
- Stable under recommended storage conditions for long-term use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.